FDA Investigator Dongping Dai, PhD
Dongping Dai, PhD has inspections in 7 countries as of 10 Oct 2023. Dongping Dai, PhD has collaborated with a combinined 3197 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
33
Last Inspection Date:
10 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China,
United States of America,
Singapore,
France,
Denmark,
United Kingdom of Great Britain and Northern Ireland,
India
Co-Investigator(s):
Alan P Kurtzberg,
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Amy W Mai,
Amy W Yan Mai,
Andrea S Heise,
Angela E Glenn,
Anita Narula, PhD,
Ann M Stewart,
Ann Marie Montemurro,
Ann Marie Schofield,
Arie C Menachem,
Ashar P Parikh,
Azza Talaat,
Barbara Janine Breithaupt,
Bijoy Panicker,
Carl Lee,
Carla J Lundi,
Carlos Chavez,
Carolina D Vasquez,
CDR Ileana Barreto Pettit,
Charanjeet Jassal,
Charisse K Green,
Christopher M Jenner,
Christopher T Middendorf,
Cynthia Jim, CSO,
Daniel J Roberts,
Darren S Brown,
David M Beltran,
David R Delucia,
Demitria J Xiradakis,
Dennis Cantellops Paite,
Dilijeta Bajrami,
Djamila Harouaka,
Dr. Gang Wang, PhD,
Dr. Robert C Horan, MD,
Dr. S Nar Ali, PhD,
Dustin M James,
Edith M Gonzalez,
Edmund F Mrak, Jr,
Edouard Viard,
Eric L Dong, BS,
Erica B Raphael,
Erik W Koester,
Erika V Butler,
Farhana Khan,
Felix Maldonado,
Gary J Lehr,
Ginger M Sykes,
Gwyn G Dickinson,
Harry J Brewer,
Helen B Ricalde,
Heriberto Negron Rivera,
Iram R Hassan, PhD,
Jaison J Eapen,
James A Liubicich,
James L Dunnie, Jr,
Jamie L Dion,
Jane L Chang,
Javier O Vega,
Jay T Wong,
Jeffery A Hangartner,
Jonathan W Chapman,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Jose M Cayuela,
Jose Martinez, Jr,
Jose O Hernandez,
Jose R Hernandez,
Joseph R Haynes,
Joy P Matthias,
Kara D Dobbin,
Karishma G Gopaul,
Katherine Szestypalow,
Kejun Cheng,
Kellia N Hicks,
Kenneth H Williams,
Kevin A Gonzalez,
Kevin P Foley,
Kham Phommachanh,
Kim Lthomas Cruse,
Kim Thomasc Rice,
Kimberley A Hoefen,
Kimberly Y Smithson,
Larry K Austin,
Latorie S Jones,
Lawrence W Farina,
LCDR Debra Emerson,
Linda F Murphy,
Lindsey M Schwierjohann,
Luis A Dasta,
Lydia Irosas Marty,
Margaret M Annes,
Marion W Nadeau,
Mariza M Jafary,
Marvin D Jones,
Mary Jeanet Mcgarry,
Matthew B Casale,
Matthew C Watson,
Matthew R Dionne,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael A Taylor,
Michael J Kuchta,
Michael L Casner,
Michael L Chasey,
Michael R Goga,
Michele L Forster, PhD,
Miguel A Martinez,
Mindy M Chou,
Monica Cburgos Garcia,
Mra M Barbosar,
Muralidhara B Gavini, PhD,
Nayan J Patel,
Neil J Bonzagni, PhD MPH,
Paraluman S Leonin,
Parul M Patel,
Patrick C Klotzbuecher,
Paul A Bonneau,
Paul L Bellamy,
Paul Mouris,
Paula A Trost,
Peter Abel,
Peter Caparelli,
Peter E Baker,
Peter R Caparelli,
Prabhu P Raju,
Qin Xu,
Rachael A Moliver,
Reba A Gates,
Rebecca E Dombrowski,
Regina T Brown,
Richard B Mcaroy,
Richard L Rutherford,
Ricki A Chase,
Robert C Steyert,
Robert J Martin,
Rochelle K Kimmel,
Roger F Zabinski,
Rose Xu,
Saleem A Akhtar,
Samantha J Bradley,
Sangeeta M Khurana, PhD,
Santos E Camara,
Sarah Ibrahim,
Satheesh Thomas,
Scott B Laufenberg,
Scott T Ballard,
Shari L Kahn,
Simone E Pitts,
Sony Mathews,
State Agency,
Stephen D Brown,
Stephen T Hansen,
Sunitha K Rajaram, PhD,
Susanne M Richardson, MSc RAC ELS,
Suwaskie S Smith,
Syed N Ali,
Thomas E Friel,
Thomas J Arista,
Thomas J Mooney,
Timothy T Kapsala,
Tracey L Harris,
Tracy M Portelli,
Truong Xuan Nguyen (Andy),
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Vilmary Negron Rodriguez,
Vlada Matusovsky,
Walden H Lee,
William A Warnick,
Yiyue Zhang (nmi), PhD,
Yumi J Hiramine,
Zachary A Bogorad,
Zachary L Miller,
Zi Qiang Gu
Dongping Dai, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2008 | FDA 483 | TIME CAP LABORATORIES, INC - Form 483, 2008-12-05 |
| December, 2008 | EIR | TIME CAP LABORATORIES, INC - EIR, 2008-12-05 |
| April, 2009 | FDA 483 | Corwood Labs Inc - Form 483, 2009-04-08 |
| April, 2013 | EIR | Almac Pharma Services Limited - EIR, 2013-04-26 |
| December, 2019 | FDA 483 | Sun Pharmaceutical Industries Limited - Form 483, 2019-12-13 |
| October, 2009 | FDA 483 | Tishcon Corp - Form 483, 2009-10-13 |
| April, 2015 | EIR | Shandong Qilu King-phar Pharmaceutical Co., Ltd. - EIR, 2015-04-24 |
| January, 2010 | FDA 483 | Actavis Laboratories UT, Inc. - Form 483, 2010-01-12 |
| January, 2010 | FDA 483 | Fougera Pharmaceuticals Inc. - Form 483, 2010-01-12 |
| March, 2008 | FDA 483 | Allegiant Health - Form 483, 2008-03-24 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more